HomeBUSINESS
BUSINESS

Sanofi, Asahi Kasei Pharma Tie Up for Anti RA Treatment Kevzara
(Dec.11.2017)

Sanofi and Asahi Kasei Pharma said on December 8 that they have entered into a license agreement for the marketing of Sanofi’s rheumatoid arthritis (RA) treatment Kevzara subcutaneous injection (sarilumab) in Japan ...
(LOG IN FOR FULL STORY)

News Calendar